Business Wire

bluebird bio Licenses Lentiviral Vector Patent Rights for Development and Commercialization of Cell Therapies

CAMBRIDGE, Mass.--(BUSINESS WIRE)--bluebird bio, Inc. (Nasdaq: BLUE) today announced that it has entered into a worldwide license agreement around its proprietary lentiviral vector platform with ...
USA Today

VectorStock Announces Single-License Model to Replace Traditional Multi-Tier Stock Licensing

A new Pro License from VectorStock replaces traditional multi-tier stock licensing with a clearer model for today’s POD and digital creators. VectorStock today announced the release of its new Pro ...
Newswire

Vector Aerospace Awarded Turbomeca Arriel 2 Engine Repair & Overhaul License

TORONTO , Oct. 14 /CNW/ - Vector Aerospace Corporation ("Vector"TSX: RNO) www.vectoraerospace.com the world's largest independent provider of aviation maintenance, repair and overhaul (MRO) services ...
PharmTech

CSL Licenses Cytegrity Lentiviral Vector Production System to Genezen

CSL will share access to Cytegrity, its proprietary stable production system for lentiviral vector production, with Genezen. Genezen, a cell and gene therapy contract development and manufacturing ...
Seeking Alpha

REGENXBIO out-licenses NAV AAV9 vector to AveXis for two neurologic disorders; shares ahead 1% after hours

REGENXBIO (NASDAQ:RGNX) extends a global exclusive license to AveXis (AVXS) to develop and commercialize gene therapies using RGNX's NAV AAV9 vector to treat Rett Syndrome and a form of amyotrophic ...
Healio

Astellas, 4D Molecular Therapeutics enter license agreement for retinotopic vector

Please provide your email address to receive an email when new articles are posted on . Astellas has gained the rights to utilize 4DMT’s R100 vector to deliver its unique genetic payloads. Astellas is ...